尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Ball Titus B.. Officer active across 2 companies, notably BeiGene, Ltd.. Cumulatively, 10 reports have been published. Breakdown: 0 buy · 7 sells. Total volume traded: €98k. Activity tracked since 5 June 2024. The latest transaction was filed on 1 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Ball Titus B. has 9 filings in total. Across the 9 sampled recent filings between 2024-06-07 and 2026-06-15, sales total EUR 57,811 and the dominant transaction type is sale. He is Principal Accounting Officer at BeOne Medicines Ltd. and BeiGene, Ltd.